Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$72.42 n/a | n/a%
12/02/16 - 04:00 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 18.11B 12.06B 3.06B 2.57B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.40B -2.58B -315.00M 197.99M
(Increase) Decrease in Inventories -855.00M 143.00M -343.00M -349.92M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 226.00M -289.00M -98.00M 117.48M
(Decrease) Increase In Other Current Liabilities 2.90B 2.55B 342.00M 248.12M
(Increase) Decrease In Other Working Capital 374.00M 31.00M 22.00M 23.25M
Other Non-Cash Items 359.00M 463.00M 363.00M 274.71M
Net Cash From Continuing Operations 20.33B 12.82B 3.10B 3.19B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 20.33B 12.82B 3.10B 3.19B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -747.00M -557.00M -190.00M -397.05M
Acquisitions 0.00 0.00 -379.00M -10.75B
Purchases of Short-Term Investments -17.24B -2.11B -257.00M -1.24B
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -12.47B -1.82B -254.00M -11.85B
Issuance of Debt 784.00M 2.54B 2.77B 213.86M
Cash Used for Financing Activities
Issuance of Capital Stock 319.00M 331.00M 313.00M 466.28M
Repayment of Long-Term Debt -997.00M -4.80B -4.44B -1.84B
Repurchase of Capital Stock -10.00B -5.35B -582.00M -667.04M
Payment of Cash Dividends -1.87B 0.00 0.00 0.00
Other Financing Charges, Net 6.81B 4.25B -609.00M 2.39B
Net Cash From Financing Activities -4.96B -3.02B -2.54B 563.35M
Effect of Exchange Rate Changes -67.00M -56.00M 2.00M 7.91M
Net Change in Cash & Cash Equivalents 2.82B 7.91B 309.00M -8.08B

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter